InVitae Corp (NYSE: NVTA) had its price target raised by analysts at Benchmark Co. from $22.00 to $26.00. They now have a "buy" rating on the stock.
Last invitae corp earnings: 11/6 04:05 pm
Check Earnings Report
US:NYSE Investor Relations: ir.invitae.com/investor-relations/default.aspx
Impact snapshot | Event time: | NVTA | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last price | ||
VWAP | ||
High:
|
Max up |
High:
|
Low:
|
Max down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
NVTA alerts
NVTA alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVTA alerts
High impacting Invitae Corp news events
Weekly update
A roundup of the hottest topics
NVTA
News
- Invitae Announces Program with BioMarin to Expand Access to Genetic Testing for Skeletal DysplasiasPR Newswire
- Genetic Testing Companies Take DNA Tests To A Whole New Level [Investor's Business Daily]Investors Business Daily
- Invitae (NYSE:NVTA) Has Debt But No Earnings; Should You Worry? [Yahoo! Finance News]Yahoo! Finance News
- Invitae - Bringing Genetic Testing To Everyone [Seeking Alpha]Seeking Alpha
- You can now buy 23andMe genetic tests and gluten sensors with FSA money [MarketWatch]MarketWatch
- More
NVTA
SEC Filings
- 11/18/19 - Form S-3ASR
- 11/15/19 - Form 4
- 11/13/19 - Form 8-K
- NVTA's page on the SEC website
- More